Prostate Radiotherapy With Adjuvant ADT Improves Metastasis-Free Survival Over Neoadjuvant ADT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis
J. Clin. Oncol 2020 Dec 04;[EPub Ahead of Print], DE Spratt, S Malone, S Roy, S Grimes, L Eapen, SC Morgan, J Malone, J Craig, RT Dess, WC Jackson, HE Hartman, AU Kishan, R Mehra, S Kaffenberger, TM Morgan, ZR Reichert, JJ Alumkal, J Michalski, WR Lee, TM Pisansky, FY Feng, W Shipley, HM Sandler, MJ Schipper, M Roach, Y Sun, CAF LawtonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.